SOCM
SR One Capital Management Portfolio holdings
AUM
$461M
This Quarter Return
-3.33%
1 Year Return
+23.25%
3 Year Return
+188.96%
5 Year Return
–
10 Year Return
–
AUM
$195M
AUM Growth
+$195M
(-16%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcellx
ACLX
$3.85B
| $142M | 72.57% |
3,946,630
| – | – |
|
2
Mineralys Therapeutics
MLYS
$1.03B
| $17.1M | 8.75% |
1,794,600
| – | – |
|
3
Design Therapeutics
DSGN
$315M
| $15.4M | 7.89% |
6,526,476
| – | – |
|
4
ARS Pharmaceuticals
SPRY
$1.15B
| $15.2M | 7.77% |
4,012,903
| – | – |
|
|
EFTR
5
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $4.03M | 2.06% |
6,822,114
| – | – |
|
6
Nkarta
NKTX
$151M
| $1.85M | 0.95% |
1,333,333
| – | – |
|